Literature DB >> 11198056

Sleep and daytime sleepiness the next day following single night-time dose of fluvoxamine, dothiepin and placebo in normal volunteers.

S J Wilson1, J E Bailey, C Alford, D J Nutt.   

Abstract

To explore the effects of sedating and non-sedating antidepressants, we conducted a placebo-controlled, double-blind cross-over study in 12 normal subjects of the effects of a single night-time dose of fluvoxamine 100 mg, dothiepin 100 mg or placebo on night-time sleep recorded at home, and sleepiness and performance the following day. Night-time sleep was altered significantly by both drugs, with main effects on rapid eye movement (REM) sleep and sleep continuity. Dothiepin increased total sleep time, REM latency and stage 2 sleep and decreased arousals, wake after sleep onset and stage 1, whereas fluvoxamine decreased total sleep time and REM time and increased wake after sleep onset. Sleep latencies in daytime naps were significantly shorter for dothiepin and longer for fluvoxamine, showing that subjects were more sleepy when taking dothiepin. Electroencephalograms (EEG) performed during performance tasks failed to distinguish significantly between drugs. There were no significant differences between groups on our measures of tracking performance or reaction time; however, these tasks were designed primarily to provide a standard setting in which to monitor continuous EEG, and were unsuitable to detect sleepiness effects themselves. Saccadic eye movement velocity, acceleration and deceleration showed small non-significant changes after both drugs. Mood self ratings showed no significant differences among the groups. Subjective measures of night-time sleep reflected the objective measures of sleep continuity, and the items for difficulty and speed of wakening in the morning were significantly higher (i.e. more difficulty and slower) in the dothiepin group. The home-recorded sleep findings after fluvoxamine in this study were very similar to sleep laboratory studies with other antidepressant drugs, thus providing more validation of the home recording method.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11198056     DOI: 10.1177/026988110001400420

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  7 in total

1.  A translational, caffeine-induced model of onset insomnia in rats and healthy volunteers.

Authors:  Louise M Paterson; Sue J Wilson; David J Nutt; Peter H Hutson; Magnus Ivarsson
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

Review 2.  Antidepressants and sleep: a qualitative review of the literature.

Authors:  Sue Wilson; Spilios Argyropoulos
Journal:  Drugs       Date:  2005       Impact factor: 9.546

Review 3.  Neurocognitive, mood changes, and sleepiness in patients with REM-predominant obstructive sleep apnea.

Authors:  Ahmed S BaHammam; Abdul Rouf Pirzada; Seithikurippu R Pandi-Perumal
Journal:  Sleep Breath       Date:  2022-03-22       Impact factor: 2.816

4.  Use of Selective Serotonin Reuptake Inhibitors and Sleep Quality: A Population-Based Study.

Authors:  Nikkie Aarts; Lisette A Zuurbier; Raymond Noordam; Albert Hofman; Henning Tiemeier; Bruno H Stricker; Loes E Visser
Journal:  J Clin Sleep Med       Date:  2016-07-15       Impact factor: 4.062

5.  Using Baclofen to Explore GABA-B Receptor Function in Alcohol Dependence: Insights From Pharmacokinetic and Pharmacodynamic Measures.

Authors:  Claire F Durant; Louise M Paterson; Sam Turton; Susan J Wilson; James F M Myers; Suresh Muthukumaraswamy; Ashwin Venkataraman; Inge Mick; Susan Paterson; Tessa Jones; Limon K Nahar; Rosa E Cordero; David J Nutt; Anne Lingford-Hughes
Journal:  Front Psychiatry       Date:  2018-12-14       Impact factor: 4.157

Review 6.  Association of Sleep Architecture and Physiology with Depressive Disorder and Antidepressants Treatment.

Authors:  Peter Hutka; Michaela Krivosova; Zuzana Muchova; Ingrid Tonhajzerova; Andrea Hamrakova; Zuzana Mlyncekova; Juraj Mokry; Igor Ondrejka
Journal:  Int J Mol Sci       Date:  2021-01-29       Impact factor: 5.923

Review 7.  The Neurobiological Mechanisms and Treatments of REM Sleep Disturbances in Depression.

Authors:  Yi-Qun Wang; Rui Li; Meng-Qi Zhang; Ze Zhang; Wei-Min Qu; Zhi-Li Huang
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.